Challenges and Advances in CAR-T Cell Therapy for B-ALL

The authors discuss the limitations of CAR-T and strategies to overcome them, specifically in the context of B cell acute lymphoblastic leukemia, including the use of allogeneic CAR-T, dual-targeted CAR-T, and combination strategies with novel technologies and agents.